IT202100002531A1 - FUNCTIONAL ANTIOXIDANT AND ANTI-INFLAMMATORY DRINK - Google Patents
FUNCTIONAL ANTIOXIDANT AND ANTI-INFLAMMATORY DRINK Download PDFInfo
- Publication number
- IT202100002531A1 IT202100002531A1 IT102021000002531A IT202100002531A IT202100002531A1 IT 202100002531 A1 IT202100002531 A1 IT 202100002531A1 IT 102021000002531 A IT102021000002531 A IT 102021000002531A IT 202100002531 A IT202100002531 A IT 202100002531A IT 202100002531 A1 IT202100002531 A1 IT 202100002531A1
- Authority
- IT
- Italy
- Prior art keywords
- weight
- inflammatory
- percentage
- antioxidant
- functional
- Prior art date
Links
- 239000003963 antioxidant agent Substances 0.000 title claims description 51
- 230000003078 antioxidant effect Effects 0.000 title claims description 43
- 230000003110 anti-inflammatory effect Effects 0.000 title claims description 33
- 229920002674 hyaluronan Polymers 0.000 claims description 33
- 229960003160 hyaluronic acid Drugs 0.000 claims description 33
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 27
- 239000000203 mixture Substances 0.000 claims description 23
- 239000000284 extract Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 10
- 244000193174 agave Species 0.000 claims description 8
- 235000013361 beverage Nutrition 0.000 claims description 8
- 239000006188 syrup Substances 0.000 claims description 8
- 235000020357 syrup Nutrition 0.000 claims description 8
- 235000013525 pomegranate juice Nutrition 0.000 claims description 7
- 229930003231 vitamin Natural products 0.000 claims description 7
- 235000013343 vitamin Nutrition 0.000 claims description 7
- 239000011782 vitamin Substances 0.000 claims description 7
- 229940088594 vitamin Drugs 0.000 claims description 7
- 235000021537 Beetroot Nutrition 0.000 claims description 6
- 229940002508 ginger extract Drugs 0.000 claims description 5
- 235000020708 ginger extract Nutrition 0.000 claims description 5
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 235000008397 ginger Nutrition 0.000 claims description 4
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 claims description 3
- 241000234314 Zingiber Species 0.000 claims description 3
- 235000016068 Berberis vulgaris Nutrition 0.000 claims description 2
- 241000335053 Beta vulgaris Species 0.000 claims description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 2
- 235000006708 antioxidants Nutrition 0.000 description 44
- 210000003491 skin Anatomy 0.000 description 19
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 17
- 230000000694 effects Effects 0.000 description 14
- 150000003254 radicals Chemical class 0.000 description 12
- 235000013305 food Nutrition 0.000 description 9
- 239000002516 radical scavenger Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 230000006378 damage Effects 0.000 description 7
- 230000009471 action Effects 0.000 description 6
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 230000032683 aging Effects 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 5
- 229940114124 ferulic acid Drugs 0.000 description 5
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 5
- 235000001785 ferulic acid Nutrition 0.000 description 5
- 235000020510 functional beverage Nutrition 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 238000006722 reduction reaction Methods 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 5
- 230000037303 wrinkles Effects 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- -1 C and B1 Natural products 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 229950006780 n-acetylglucosamine Drugs 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000002195 synergetic effect Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 3
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 3
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000013068 control sample Substances 0.000 description 3
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 3
- 239000003344 environmental pollutant Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 235000013376 functional food Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 231100000719 pollutant Toxicity 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000036642 wellbeing Effects 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- NULAJYZBOLVQPQ-UHFFFAOYSA-N N-(1-naphthyl)ethylenediamine Chemical compound C1=CC=C2C(NCCN)=CC=CC2=C1 NULAJYZBOLVQPQ-UHFFFAOYSA-N 0.000 description 2
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 description 2
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000012954 diazonium Substances 0.000 description 2
- 150000001989 diazonium salts Chemical class 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000003912 environmental pollution Methods 0.000 description 2
- 150000004676 glycans Polymers 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 238000006213 oxygenation reaction Methods 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 150000005839 radical cations Chemical class 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 235000014214 soft drink Nutrition 0.000 description 2
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 2
- 229940124530 sulfonamide Drugs 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- XZRVRYFILCSYSP-HNNXBMFYSA-N (R)-β-bisabolene Chemical compound CC(C)=CCCC(=C)[C@@H]1CCC(C)=CC1 XZRVRYFILCSYSP-HNNXBMFYSA-N 0.000 description 1
- WCBPJVKVIMMEQC-UHFFFAOYSA-N 1,1-diphenyl-2-(2,4,6-trinitrophenyl)hydrazine Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1NN(C=1C=CC=CC=1)C1=CC=CC=C1 WCBPJVKVIMMEQC-UHFFFAOYSA-N 0.000 description 1
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 102100032912 CD44 antigen Human genes 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 241000871189 Chenopodiaceae Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 1
- 229910002567 K2S2O8 Inorganic materials 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 240000003394 Malpighia glabra Species 0.000 description 1
- 235000014837 Malpighia glabra Nutrition 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 206010040829 Skin discolouration Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 206010047141 Vasodilatation Diseases 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 241000234299 Zingiberaceae Species 0.000 description 1
- ZTOJFFHGPLIVKC-CLFAGFIQSA-N abts Chemical compound S/1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C\1=N\N=C1/SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-CLFAGFIQSA-N 0.000 description 1
- 239000002535 acidifier Substances 0.000 description 1
- 229940095602 acidifiers Drugs 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000240 adjuvant effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000016571 aggressive behavior Effects 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000000987 azo dye Substances 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- 239000013553 cell monolayer Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- LBJNMUFDOHXDFG-UHFFFAOYSA-N copper;hydrate Chemical compound O.[Cu].[Cu] LBJNMUFDOHXDFG-UHFFFAOYSA-N 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000006193 diazotization reaction Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical class CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 1
- 235000002780 gingerol Nutrition 0.000 description 1
- 229940038487 grape extract Drugs 0.000 description 1
- 235000002532 grape seed extract Nutrition 0.000 description 1
- 229940087603 grape seed extract Drugs 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000036732 histological change Effects 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000004324 lymphatic system Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 150000002826 nitrites Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 235000019394 potassium persulphate Nutrition 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- KKOXKGNSUHTUBV-UHFFFAOYSA-N racemic zingiberene Natural products CC(C)=CCCC(C)C1CC=C(C)C=C1 KKOXKGNSUHTUBV-UHFFFAOYSA-N 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 230000037067 skin hydration Effects 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000005062 synaptic transmission Effects 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- YMBCJWGVCUEGHA-UHFFFAOYSA-M tetraethylammonium chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC YMBCJWGVCUEGHA-UHFFFAOYSA-M 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 239000001717 vitis vinifera seed extract Substances 0.000 description 1
- 210000004127 vitreous body Anatomy 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- KKOXKGNSUHTUBV-LSDHHAIUSA-N zingiberene Chemical compound CC(C)=CCC[C@H](C)[C@H]1CC=C(C)C=C1 KKOXKGNSUHTUBV-LSDHHAIUSA-N 0.000 description 1
- 229930001895 zingiberene Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/58—Colouring agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
DESCRIZIONE DESCRIPTION
del brevetto per invenzione industriale dal titolo: ?Bevanda funzionale antiossidante ed antinfiammatoria? of the patent for industrial invention entitled: ?Functional antioxidant and anti-inflammatory drink?
La presente invenzione ? relativa ad una bevanda funzionale antiossidante ed antinfiammatoria. The present invention ? relating to a functional antioxidant and anti-inflammatory beverage.
Come ? noto, il legame esistente tra dieta e benessere psicofisico condiziona fortemente le scelte nutrizionali del moderno consumatore, la cui domanda di alimenti contenenti specifici ingredienti benefici per la salute cresce parallelamente alla disponibilit? di informazioni sull?argomento. Gli alimenti, infatti, non sono destinati solo a soddisfare il senso della fame ma forniscono i nutrienti indispensabili all?organismo per il mantenimento della vita, per prevenire le malattie legate all?alimentazione e per migliorare il benessere fisico e mentale. As ? Known, the link between diet and psychophysical well-being strongly affects the nutritional choices of the modern consumer, whose demand for foods containing specific health-promoting ingredients grows in parallel with the availability? of information on the subject. Foods, in fact, are not intended only to satisfy the sense of hunger but provide the nutrients essential to the body for the maintenance of life, to prevent food-related diseases and to improve physical and mental well-being.
Gli alimenti funzionali rappresentano un settore in rapidissima evoluzione ed i progressi nel campo della scienza e della tecnologia alimentare, stanno fornendo metodologie sempre pi? efficienti nel migliorare la composizione di questi prodotti. Inoltre, l?introduzione di effetti nutrizionali e salutistici rappresenta una grande opportunit? per l?industria agroalimentare per riposizionare i propri prodotti e per svilupparne di nuovi. Functional foods represent a rapidly evolving sector and advances in the field of food science and technology are providing ever more effective methodologies. efficient in improving the composition of these products. Furthermore, the introduction of nutritional and health effects represents a great opportunity? for the agro-food industry to reposition its products and to develop new ones.
In base alla definizione dell?European Food Information Council (EUFIC) del 1999, ?un alimento pu? essere considerato funzionale se dimostra in maniera soddisfacente di avere effetti positivi su una o pi? funzioni specifiche dell?organismo, che vadano oltre gli effetti nutrizionali normali, in modo tale che sia rilevante per il miglioramento dello stato di salute e di benessere e/o per la riduzione del rischio di malattia.?. According to the definition of the European Food Information Council (EUFIC) of 1999, ?a food can? be considered functional if it satisfactorily demonstrates that it has positive effects on one or more? specific functions of the body, which go beyond the normal nutritional effects, in a way that is relevant to the improvement of health and well-being and/or the reduction of the risk of disease.?.
La propensione a nutrirsi in modo ?sano? ha incoraggiato l?industria alimentare a sviluppare la sperimentazione e la commercializzazione di nuovi alimenti funzionali, gradevoli al gusto, pronti all?uso e facilmente reperibili. The propensity to eat in a ?healthy? has encouraged the food industry to develop the experimentation and marketing of new functional foods, pleasant to the taste, ready to use and easily available.
Un'importante categoria di prodotto all'interno degli alimenti funzionali ? costituita dalle bevande analcoliche arricchite con vitamine, antiossidanti o altri ingredienti funzionali. Le bevande funzionali, infatti, stanno suscitando in questi ultimi anni un interesse crescente, in quanto conferiscono un valore salutistico e nutrizionale ad alimenti gradevoli, leggeri e dissetanti. An important product category within functional foods? consisting of soft drinks enriched with vitamins, antioxidants or other functional ingredients. In fact, functional drinks have been arousing growing interest in recent years, as they give a healthy and nutritional value to pleasant, light and thirst-quenching foods.
? noto inoltre, che l'invecchiamento cutaneo ? un processo fisiologico caratterizzato dalla progressiva perdita di acido ialuronico e collagene, formazione di rughe sempre pi? profonde, comparsa di discromie localizzate o diffuse e perdita di tonicit?. Accanto ad una predisposizione genetica peculiare per ciascun individuo, che determina la progressione dell?invecchiamento cutaneo inducendo una maggiore o minore precocit? nella manifestazione dei sintomi, troviamo una serie di fattori esogeni in grado di accelerare tale processo, quali raggi UVA, UVB, Infrarossi ed Inquinamento Ambientale. ? I also know that skin aging is a physiological process characterized by the progressive loss of hyaluronic acid and collagen, the formation of wrinkles more and more deep, appearance of localized or widespread dyschromia and loss of tone. Alongside a specific genetic predisposition for each individual, which determines the progression of skin aging by inducing a greater or lesser precocity in the manifestation of symptoms, we find a series of exogenous factors capable of accelerating this process, such as UVA, UVB, infrared rays and environmental pollution.
Vari studi hanno dimostrato che l'inquinamento ambientale ? in grado di accelerare l?invecchiamento e la comparsa di allergie cutanee. La pelle, infatti, risulta particolarmente esposta all'aggressione di tutti gli elementi inquinanti che riescono a penetrare la barriera cutanea. Various studies have shown that environmental pollution is able to accelerate aging and the appearance of skin allergies. In fact, the skin is particularly exposed to the aggression of all the polluting elements that manage to penetrate the skin barrier.
Gli agenti inquinanti (Pollutants) sono molteplici e sono in grado di determinare una serie di danni specifici: There are many pollutants (Pollutants) and they are able to cause a series of specific damages:
- danno foto-ossidante causato da reazioni chimiche fra gli idrocarburi dei gas di scarico e le radiazioni solari; - photo-oxidant damage caused by chemical reactions between the hydrocarbons in the exhaust gases and solar radiation;
- danno legato alle sostanze acide presenti in sospensione; - damage linked to the acid substances present in suspension;
- danno metabolico dovuto ai metalli pesanti; - metabolic damage due to heavy metals;
- danno da scarsa ossigenazione legato alla presenza di monossido di carbonio. - damage from poor oxygenation linked to the presence of carbon monoxide.
Il risultato ? documentabile sotto forma di un aumento dei radicali liberi dell?ossigeno (ROS) prodotti a livello endocellulare, con conseguente alterazione del film idrolipidico cutaneo, diminuita ossigenazione dei tessuti ed alterazione della funzionalit? cellulare. The result ? documented in the form of an increase in oxygen free radicals (ROS) produced at the endocellular level, with consequent alteration of the skin hydrolipidic film, decreased oxygenation of the tissues and alteration of the skin's functionality. mobile phone.
? quindi di primaria importanza proteggere la pelle sia dall?esterno, con l?utilizzo di cosmetici contenenti principi attivi antiossidanti, sia dall?interno con alimenti antiossidanti per combattere l'azione dei radicali liberi e la conseguente comparsa di rughe e macchie. ? therefore it is of primary importance to protect the skin both from the outside, with the use of cosmetics containing antioxidant active ingredients, and from the inside with antioxidant foods to fight the action of free radicals and the consequent appearance of wrinkles and spots.
Le bevande analcoliche arricchite con vitamine, antiossidanti o altri ingredienti funzionali sono tra i prodotti in grado di integrare l?alimentazione con effetti benefici, anche antiossidanti. Soft drinks enriched with vitamins, antioxidants or other functional ingredients are among the products capable of integrating nutrition with beneficial effects, including antioxidants.
Un esempio di bevanda antiossidante nota ? descritta nel brevetto ITTO20121057A1. In particolare viene descritta una bevanda con potere antiossidante, utile a prevenire malattie degenerative o rallentare il naturale processo di invecchiamento contrastando la formazione di radicali liberi nell?organismo, attraverso gli effetti sinergici esercitati dai suoi ingredienti attivi. In una forma relizzativa preferita la bevanda comprende estratto d?uva ricco in polifenoli, estratto di semi d?uva ricco in proantocianidine, estratto di mela ricco in catechine e vitamina C. La bevanda in oggetto presenta un potere antiossidante pari a circa 1,77 TEAC/100 g, e pu? contenere sostanze coloranti naturali quali caramello, zucchero bruciato o estratti vegetali con potere colorante. An example of a known antioxidant drink ? described in the patent ITTO20121057A1. In particular, a drink with antioxidant power is described, useful for preventing degenerative diseases or slowing down the natural aging process by counteracting the formation of free radicals in the body, through the synergistic effects exerted by its active ingredients. In a preferred embodiment, the beverage comprises grape extract rich in polyphenols, grape seed extract rich in proanthocyanidins, apple extract rich in catechins and vitamin C. The beverage in question has an antioxidant power of about 1.77 TEAC/100 g, and can? contain natural coloring substances such as caramel, burnt sugar or plant extracts with coloring power.
Ulteriore esempio di bevanda funzionale ? quella descritta nel documento JP2006056809A che descrive una bevanda cosmetologica contenente acido ialuronico e N-acetilglucosamina. I test effettuati hanno evidenziato che la N-acetilglucosamina ingerita per via orale viene convertita in acido ialuronico nel corpo, cos? che quando una persona ingerisce una bevanda contenente N-acetilglucosamina insieme ad acido ialuronico, quest?ultimo permane pi? a lungo nel tessuto cutaneo, contribuendo a un effetto di antiinvecchiamento della pelle. In dettaglio. la bevanda contiene vitamina C e altre vitamine che hanno un effetto di prevenzione contro la formazione di macchie cutanee. Frutti, dolcificanti, agenti aromatizzanti, acidificanti e coloranti possono essere aggiunti per migliorare il gusto e l?aroma. Tali additivi opzionali includono, ad esempio, vitamine come la C e la B1, e altri elementi come l'acerola, il mandarino, l?arancia, il limone e l?ananas. Another example of a functional drink ? the one described in document JP2006056809A which describes a cosmetological drink containing hyaluronic acid and N-acetylglucosamine. Tests have shown that orally ingested N-acetylglucosamine is converted into hyaluronic acid in the body, thus that when a person ingests a drink containing N-acetylglucosamine together with hyaluronic acid, the latter remains longer? in the skin tissue for a long time, contributing to an anti-aging effect on the skin. In detail. the drink contains vitamin C and other vitamins which have a preventive effect against the formation of skin spots. Fruits, sweeteners, flavoring agents, acidifiers and colors can be added to improve taste and aroma. Such optional additives include, for example, vitamins such as C and B1, and other elements such as acerola, mandarin, orange, lemon and pineapple.
Tuttavia le bevande funzionali ad effetto antiossidante ed antinfiammatorio attualmente note, non hanno composizione ottimizzata n? una formulazione tale che i componenti agiscano in modo sinergico, potenziando in modo combinato le loro propriet? benefiche. However, the currently known functional beverages with an antioxidant and anti-inflammatory effect do not have an optimized composition or a formulation such that the components act synergistically, enhancing their properties in a combined way? beneficial.
Infine, le bevande funzionali antiossidanti ed antinfiammatorie attualmente note non hanno ingredienti e composizione caratterizzata da estratti vegetali locali e comuni nell?area mediterranea. Finally, the currently known antioxidant and anti-inflammatory functional beverages do not have ingredients and compositions characterized by local and common plant extracts in the Mediterranean area.
Scopo della presente invenzione ? fornire una bevanda funzionale antiossidante ed antinfiammatoria avente una formulazione ed una composizione ottimizzata, formulata in modo tale da contribuire alla protezione delle cellule dallo stress ossidativo, grazie alla presenza ed all?effetto sinergico di sostanze antiossidanti, e al mantenimento dello stato fisiologico della pelle integrando la carenza di acido ialuronico che si genera con l?avanzare dell?et?. Purpose of the present invention? provide a functional antioxidant and anti-inflammatory drink having an optimized formulation and composition, formulated in such a way as to contribute to the protection of cells from oxidative stress, thanks to the presence and synergistic effect of antioxidant substances, and to maintain the physiological state of the skin by integrating the lack of hyaluronic acid that is generated with the advance of age.
Ulteriore scopo della presente invenzione ? fornire un metodo di produzione di una bevanda funzionale antiossidante ed antinfiammatoria, secondo l?invenzione. Another purpose of the present invention ? to provide a method of producing a functional antioxidant and anti-inflammatory beverage, according to the invention.
Per una migliore comprensione della presente invenzione viene ora descritta una forma di realizzazione preferita, a puro titolo di esempio non limitativo, con riferimento ai disegni allegati, nei quali: For a better understanding of the present invention, a preferred embodiment is now described, purely by way of non-limiting example, with reference to the attached drawings, in which:
- la figura 1 mostra una reazione di riduzione oggetto di test sperimentali sulla bevanda funzionale antiossidante ed antinfiammatoria, secondo l?invenzione; - figure 1 shows a reduction reaction object of experimental tests on the functional antioxidant and anti-inflammatory beverage, according to the invention;
- la figura 2 mostra primi risultati sperimentali sulla bevanda funzionale antiossidante ed antinfiammatoria, secondo l?invenzione; - figure 2 shows first experimental results on the antioxidant and anti-inflammatory functional drink, according to the invention;
- la figura 3 mostra secondi risultati sperimentali sulla bevanda funzionale antiossidante ed antinfiammatoria, secondo l?invenzione; - figure 3 shows second experimental results on the antioxidant and anti-inflammatory functional beverage, according to the invention;
- la figura 4 mostra una reazione oggetto di test sperimentali sulla bevanda funzionale antiossidante ed antinfiammatoria, secondo l?invenzione; - figure 4 shows a reaction object of experimental tests on the functional antioxidant and anti-inflammatory beverage, according to the invention;
- la figura 5 mostra terzi risultati sperimentali sulla bevanda funzionale antiossidante ed antinfiammatoria, secondo l?invenzione. - figure 5 shows third experimental results on the antioxidant and anti-inflammatory functional drink, according to the invention.
Secondo la presente invenzione, la bevanda funzionale antiossidante ed antinfiammatoria contiene: According to the present invention, the functional antioxidant and anti-inflammatory drink contains:
- Una miscela di acido ialuronico a peso molecolare alto, medio e basso; - A blend of high, medium and low molecular weight hyaluronic acid;
- Estratto di zenzero; - Ginger extract;
- Estratto di Barbabietola rossa; - Beetroot extract;
- Sciroppo d?agave. - Agave syrup.
L?acido ialuronico (HA) rappresenta uno dei principali componenti della matrice extracellulare dei tessuti dei vertebrati. Questo mucopolisaccaride si ritrova nell'umor vitreo dell'occhio, nel liquido sinoviale, nella pelle, nella cartilagine e nei tendini. Dal punto di vista chimico ? un glicosaminoglicano non solforato la cui catena polisaccaridica non ramificata ? costituita da unit? ripetitive disaccaridiche formate da residui di acido ?-1,4-D-glucuronico e ?-1,3-N-acetil-D-glucosamina. Hyaluronic acid (HA) is one of the main components of the extracellular matrix of vertebrate tissues. This mucopolysaccharide is found in the vitreous humor of the eye, synovial fluid, skin, cartilage and tendons. Chemically? a non-sulfur glycosaminoglycan whose unbranched polysaccharide chain ? made up of units repetitive disaccharides formed by residues of ?-1,4-D-glucuronic acid and ?-1,3-N-acetyl-D-glucosamine.
In tutti i vertebrati oltre il 50% dell?acido ialuronico totale del corpo ? presente nella pelle. L'HA ? responsabile della regolazione dell'equilibrio idrico nella pelle e del mantenimento della struttura cellulare nel derma, ed ? coinvolto nella proliferazione e differenziazione dei cheratinociti nell'epidermide. In all vertebrates, over 50% of the total body hyaluronic acid is ? present in the skin. IT HAS ? responsible for regulating the water balance in the skin and maintaining cell structure in the dermis, and is involved in the proliferation and differentiation of keratinocytes in the epidermis.
Come gi? anticipato, l?invecchiamento della pelle ? diviso in invecchiamento intrinseco legato all'et? e fotoinvecchiamento indotto da radiazione ultravioletta (UV). La pelle invecchiata ? caratterizzata da rughe, secchezza, rugosit?, macchie, cambiamenti istologici e ridotta funzione di barriera. Questi sintomi sono causati da diminuzione del collagene, decomposizione dell'HA, aumento della metalloproteasi e ossigeno reattivo nella pelle. L'HA ingerito aumenta il contenuto di umidit? della pelle nei soggetti con pelle secca. Infatti, secondo vari studi, l'HA somministrato per via orale viene assorbito intatto, nonch? sotto forma di metaboliti decomposti da batteri intestinali e in seguito rilevato nella pelle. Infatti, HA con basso peso molecolare viene assorbito principalmente attraverso il monostrato di cellule Caco-2 dopo somministrazione orale. Mentre l?HA con alto peso molecolare viene in parte decomposto in acido ialuronico a basso peso molecolare dai batteri intestinali ed assorbito ed in parte viene assorbito tal quale dal sistema linfatico. Inoltre, poich? l?HA ad alto peso molecolare riduce l'apoptosi indotta dai raggi UV nelle cellule corneali epiteliali umane [20], la somministrazione di HA per via orale pu? anche sopprimere l'apoptosi indotta dai raggi UV nelle cellule epidermiche, prevenendo l'aumento dello spessore epidermico. How already? anticipated, the aging of the skin ? divided into intrinsic aging related to age? and photoaging induced by ultraviolet (UV) radiation. Aged skin? characterized by wrinkles, dryness, roughness, spots, histological changes and reduced barrier function. These symptoms are caused by decreased collagen, decomposition of HA, increased metalloprotease and reactive oxygen in the skin. Does ingested HA increase the moisture content? skin in people with dry skin. In fact, according to various studies, orally administered HA is absorbed intact, as well as? in the form of metabolites broken down by intestinal bacteria and later detected in the skin. Indeed, low molecular weight HA is mainly absorbed through the Caco-2 cell monolayer after oral administration. While the HA with high molecular weight is partly decomposed into low molecular weight hyaluronic acid by intestinal bacteria and absorbed and partly is absorbed as such by the lymphatic system. Furthermore, since high molecular weight HA reduces UV-induced apoptosis in human corneal epithelial cells [20], oral administration of HA can also suppress UV-induced apoptosis in epidermal cells, preventing the increase of epidermal thickness.
L'azione dell?acido ialuronico introdotto per via orale si rivela perci? utile per sostenere l'idratazione cutanea, mantenendo la pelle pi? soda e luminosa, con meno rughe. Vista l'importanza dell'acido ialuronico per l'organismo, e considerato l'inevitabile calo delle sue concentrazioni con l'invecchiamento, molte persone sono alla ricerca di un integratore che possa in qualche modo aumentare le concentrazioni di questo polisaccaride nei vari tessuti. Il mix di Acido Ialuronico con basso, medio e alto peso molecolare utilizzato nella bevanda secondo l?invenzione ? una miscela che contiene molecole di Acido Ialuronico con uno spettro vario di pesi molecolari, che costituisce un buon compromesso in termini di stabilit? enzimatica e attivit? antinfiammatoria. L?utilizzo di una miscela, o blend, di acido ialuronico con vario peso molecolare consente una moderata biodisponibilit? dell?HA che entra direttamente in circolo e interagisce con il recettore cellulare, principalmente il CD44, creando cos? le basi per un fisiologico ringiovanimento della pelle. The action of hyaluronic acid introduced orally is revealed therefore? useful for supporting skin hydration, keeping the skin more? firm and luminous, with fewer wrinkles. Given the importance of hyaluronic acid for the body, and given the inevitable decline in its concentrations with ageing, many people are looking for a supplement that can somehow increase the concentrations of this polysaccharide in various tissues. The mix of Hyaluronic Acid with low, medium and high molecular weight used in the drink according to the invention? a mixture that contains molecules of Hyaluronic Acid with a varied spectrum of molecular weights, which constitutes a good compromise in terms of stability? enzyme and activity anti-inflammatory. The use of a mixture, or blend, of hyaluronic acid with various molecular weight allows a moderate bioavailability of HA which enters the bloodstream directly and interacts with the cellular receptor, mainly CD44, thus creating the basis for a physiological rejuvenation of the skin.
Lo zenzero, altro componente della bevanda funzionale secondo l?invenzione, ? una pianta erbacea appartenente alla famiglia delle Zingiberaceae. Il rizoma contiene i principi attivi della pianta quali Gingeroli, derivati dei gingeroli e componenti volatili dell'olio essenziale (sesquiterpeni come lo zingiberene e B-bisabolene). Tra le innumerevoli propriet? benefiche dello zenzero ci sono quelle antiossidanti e antinfiammatorie. Ginger, another component of the functional drink according to the invention, is a herbaceous plant belonging to the Zingiberaceae family. The rhizome contains the active ingredients of the plant such as gingerols, gingerol derivatives and volatile components of the essential oil (sesquiterpenes such as zingiberene and B-bisabolene). Among the countless properties Benefits of ginger are the antioxidant and anti-inflammatory ones.
La barbabietola rossa ? una pianta appartenente alla famiglia Chenopodiaceae. ? ricca di sali minerali, vitamine e flavonoidi, in particolare degli antociani, responsabili della sua tipica colorazione rosso acceso, che le conferiscono propriet? antiossidanti. Red beetroot? a plant belonging to the Chenopodiaceae family. ? rich in mineral salts, vitamins and flavonoids, in particular anthocyanins, responsible for its typical bright red colour, which give it properties antioxidants.
Il succo ? ricco di polifenoli, un gruppo eterogeneo di sostanze naturali, particolarmente note per la loro azione positiva sulla salute umana. I polifenoli sono infatti antiossidanti naturali che possono risultare utili nella prevenzione dell'ossidazione delle lipoproteine e nella protezione delle cellule dai danni causati dai radicali liberi, che si sviluppano con il normale metabolismo cellulare e a causa di eventi esterni, come radiazioni, fumo, agenti inquinanti, raggi UV, ecc. Sono accertati, inoltre, effetti biomedici positivi a livello cardiovascolare e in caso di processi infiammatori. The juice ? rich in polyphenols, a heterogeneous group of natural substances, particularly known for their positive action on human health. In fact, polyphenols are natural antioxidants that can be useful in preventing the oxidation of lipoproteins and in protecting cells from damage caused by free radicals, which develop with normal cellular metabolism and due to external events, such as radiation, smoke, pollutants , UV rays, etc. Furthermore, positive biomedical effects on the cardiovascular level and in the case of inflammatory processes have been ascertained.
Il succo di melograno contiene molti antiossidanti, i quali hanno la propriet? di neutralizzare l?azione ossidante dei radicali liberi nel nostro corpo. Il processo ossidativo dei radicali liberi ? responsabile dei danni alle cellule del corpo e questo porta alla comparsa di rughe e mancanza di elasticit? nella pelle. Pomegranate juice contains many antioxidants, which have the property to neutralize the oxidizing action of free radicals in our body. The oxidative process of free radicals ? responsible for damage to body cells and this leads to the appearance of wrinkles and lack of elasticity. in the skin.
Secondo un aspetto dell?invenzione, la bevanda funzionale antiossidante ed antinfiammatoria e composta da: According to one aspect of the invention, the antioxidant and anti-inflammatory functional drink is composed of:
- Acqua in percentuale in peso compresa tra 45% e 55%, preferibilmente pari a 50.75%; - Water in weight percentage comprised between 45% and 55%, preferably equal to 50.75%;
- Estratto di zenzero, in percentuale in peso compresa tra 0,1% e 2%, preferibilmente pari al 0.5%; - Ginger extract, in a percentage by weight between 0.1% and 2%, preferably equal to 0.5%;
- Estratto di barbabietola, in percentuale in peso compresa tra 0.1% e 2%, preferibilmente pari al 0.5%; - Beetroot extract, in a percentage by weight between 0.1% and 2%, preferably equal to 0.5%;
- Succo di melograno, in percentuale in peso compresa tra 35% e 45%, preferibilmente pari al 40%; - Pomegranate juice, in a percentage by weight between 35% and 45%, preferably equal to 40%;
- Acido ialuronico con peso molecolare MV (1000-1800) in percentuale in peso compresa tra 0.1% e 1%, preferibilmente pari al 0.2%; - Hyaluronic acid with molecular weight MV (1000-1800) in weight percentage comprised between 0.1% and 1%, preferably equal to 0.2%;
- Acido ialuronico (50-200) con percentuale in peso compresa tra 0.01% e 1%, preferibilmente pari a 0.05%. - Hyaluronic acid (50-200) with a weight percentage between 0.01% and 1%, preferably equal to 0.05%.
Secondo un aspetto dell?invenzione, la bevanda funzionale comprende inoltre: According to one aspect of the invention, the functional beverage further comprises:
- Sciroppo di agave, in percentuale in peso compresa tra 5% e 10%, preferibilmente pari al 8%. - Agave syrup, in a percentage by weight between 5% and 10%, preferably equal to 8%.
Secondo un aspetto dell?invenzione, la bevanda funzionale antiossidante ed antinfiammatoria comprende nella sua formulazione vitamine del gruppo B. According to one aspect of the invention, the antioxidant and anti-inflammatory functional drink comprises vitamins of group B in its formulation.
Il metodo di produzione della bevanda funzionale antiossidante ed antinfiammatoria secondo l?invenzione comprende le seguenti fasi: The production method of the antioxidant and anti-inflammatory functional drink according to the invention comprises the following steps:
- Effettuare un?estrazione in acqua di zenzero; - Carry out an extraction in ginger water;
- Effettuare un?estrazione in acqua di barbabietola; - Estrarre il succo di melograno; - Carry out an extraction of beets in water; - Extract the pomegranate juice;
- Estrarre lo sciroppo di agave; - Extract the agave syrup;
- Produrre un blend di acido ialuronico a diversi peso molecolare; - Produce a blend of hyaluronic acid with different molecular weights;
- Mescolare a freddo i predetti ingredienti nelle quantit? previste dalla bevanda secondo l?invenzione. - Cold mix the aforementioned ingredients in the quantities provided by the drink according to the invention.
Il Richiedente a supporto della composizione ottimizzata della bevanda funzionale antiossidante ed antinfiammatoria secondo l?invenzione, e dell?effetto coadiuvante, sinergico e combinato dei singoli componenti, ha effettuato dei test di efficacia di cui nel seguito si riporta il risultato. In support of the optimized composition of the antioxidant and anti-inflammatory functional drink according to the invention, and of the adjuvant, synergistic and combined effect of the individual components, the Applicant has carried out efficacy tests, the results of which are reported below.
L?attivit? antiossidante totale della bevanda funzionale secondo l?invenzione ? stata valutata secondo metodo riportato in letteratura opportunamente modificato. The activity total antioxidant of the functional drink according to the invention ? was evaluated according to the method reported in the literature, suitably modified.
Il saggio si basa su una reazione redox. Tale test, infatti, rappresenta un indice diretto del potere redox di una sostanza ed ? basato sulla riduzione del Mo (VI) a Mo (V) con successiva formazione, a pH acido, di un complesso fosfato-Mo(V) di colore verde e con un massimo di assorbimento a 695 nm. The assay is based on a redox reaction. This test, in fact, represents a direct index of the redox power of a substance and is based on the reduction of Mo (VI) to Mo (V) with subsequent formation, at acid pH, of a green phosphate-Mo(V) complex with a maximum absorption at 695 nm.
L?attivit? antiossidante totale ? stata espressa come milligrammi equivalenti di acido ferulico (FA) per grammo di campione (mg eq FA/g) confrontando i dati ricavati dagli esperimenti condotti con la curva di calibrazione del composto di riferimento, registrata impiegando 5 diverse soluzioni standard di FA. I risultati ottenuti sulla bevanda funzionale secondo l?invenzione sono di un?attivit? antiossidante totale pari a 59 mg eq FA/g. The activity total antioxidant ? was expressed as equivalent milligrams of ferulic acid (FA) per gram of sample (mg eq FA/g) by comparing the data obtained from the experiments conducted with the calibration curve of the reference compound, recorded using 5 different standard solutions of FA. The results obtained on the functional drink according to the invention are of an activity total antioxidant equal to 59 mg eq FA/g.
Il Richiedente ha inoltre effettuato prove mirate alla valutazione dell'attivit? antiossidante, azione scavenger sul radicale DPPH. Has the Applicant also carried out tests aimed at evaluating the activity? antioxidant, scavenger action on DPPH radical.
Il DPPH (2,2?-diphenyl-1-picrylhydrazyl) ? un radicale libero organico con un picco massimo di assorbimento a 515-528 nm e permette di valutare l?attivit? antiossidante di diversi composti mediante una misura di tipo spettrofotometrico. La reazione prevede la riduzione del radicale DPPH da parte delle molecole antiossidanti con formazione di un composto di colore giallo, la difenilpicrilidrazina (Figura 1). L?entit? della reazione di riduzione dipende dalla capacit? delle molecole di fungere da donatori di elettroni. DPPH (2,2?-diphenyl-1-picrylhydrazyl) ? an organic free radical with a maximum absorption peak at 515-528 nm and allows to evaluate the activity? antioxidant of various compounds by means of a spectrophotometric type measurement. The reaction involves the reduction of the DPPH radical by the antioxidant molecules with the formation of a yellow compound, diphenylpicrylhydrazine (Figure 1). The entity? of the reduction reaction depends on the capacity? of the molecules to act as electron donors.
Al fine di valutare le propriet? antiossidanti della bevanda funzionale secondo l?invenzione, l?attivit? scavenger contro i radicali DPPH ? stata determinata secondo metodo riportato in letteratura e opportunamente modificato. L?esperimento ? stato condotto contemporaneamente anche su un campione di controllo, preparato in assenza di campione e contenente un?equivalente quantit? di acqua distillata. In order to evaluate the properties antioxidants of the functional drink according to the invention, the activity? scavenger against DPPH radicals ? was determined according to the method reported in the literature and suitably modified. The experiment? been conducted simultaneously also on a control sample, prepared in the absence of a sample and containing an?equivalent amount? of distilled water.
L?assorbanza ? stata letta a 517 nm. I dati sono stati espressi come percentuale di inibizione calcolata secondo l'Equazione: The absorbance ? was read at 517 nm. Data were expressed as percentage inhibition calculated according to Equation:
in cui A0 rappresenta l?assorbanza del controllo e A1 ? l?assorbanza del campione analizzato. where A0 represents the absorbance of the control and A1 ? the absorbance of the analyzed sample.
I dati ottenuti dagli studi condotti dal Richiedente, hanno evidenziato la capacit? della bevanda funzionale secondo l?invenzione di inibire il radicale. I risultati ottenuti riportano un?inibizione radicale DPPH del 53,02%. The data obtained from the studies conducted by the Applicant, have highlighted the ability? of the functional drink according to the invention to inhibit the radical. The results obtained report a DPPH radical inhibition of 53.02%.
Il Richiedente ha inoltre effettuato analisi e test finalizzati alla determinazione dell?attivit? antiossidante ovvero l?azione scavenger sul radicale ABTS. Has the Applicant also carried out analyzes and tests aimed at determining the activity? antioxidant or rather the scavenger action on the ABTS radical.
L?ABTS (2,2'-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid)) ? un radicale di natura idrofila che presenta un massimo di assorbimento intorno a 734 nm. Anche in questo caso la reazione dipende dalla capacit? di donare atomi di idrogeno da parte dell?antiossidante. L'azione scavanger sul radicale ABTS ? stata studiata mediante misurazione dell'assorbanza del catione radicale (ABTS ? ) secondo il metodo riportato in letteratura opportunamente modificato [27]. Questo metodo si basa sulla capacit? degli antiossidanti agire sul catione radicale ABTS, un cromoforo blu-verde con un assorbimento caratteristico a 734 nm. ABTS ? ? stato generato dalla reazione di una soluzione acquosa di ABTS (7 mM) con persolfato di potassio 2,45 mM (K2S2O8). La miscela ottenuta ? stata lasciata al buio a temperatura ambiente e, dopo 16 ore, ? stata diluita con acqua distillata ad un'assorbanza di 0,999 ? 0,030 a 734 nm. L?esperimento ? stato condotto contemporaneamente anche su un campione di controllo, preparato in assenza di campione e contenente un?equivalente quantit? di acqua distillata. L?ABTS (2,2'-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid)) ? a radical of hydrophilic nature which has an absorption maximum around 734 nm. Also in this case the reaction depends on the capacity? to donate hydrogen atoms by the antioxidant. The scavenger action on the radical ABTS ? was studied by measuring the absorbance of the radical cation (ABTS ? ) according to the method reported in the literature suitably modified [27]. This method is based on the ability? of antioxidants act on the radical cation ABTS, a blue-green chromophore with characteristic absorption at 734 nm. ABTS ? ? was generated by the reaction of an aqueous solution of ABTS (7 mM) with 2.45 mM potassium persulfate (K2S2O8). The mixture obtained? been left in the dark at room temperature and, after 16 hours, ? been diluted with distilled water to an absorbance of 0.999 ? 0.030 at 734 nm. The experiment? been conducted simultaneously also on a control sample, prepared in the absence of a sample and containing an?equivalent quantity? of distilled water.
I dati ottenuti sono espressi come percentuale di inibizione del radicale, calcolati secondo l?Equazione (1) e pari a un?inibizione radicale ABTS del 79.03%. The data obtained are expressed as a percentage of inhibition of the radical, calculated according to Equation (1) and equal to an ABTS radical inhibition of 79.03%.
Infine, il Richiedente a supporto delle propriet? della bevanda e dell?effetto sinergico dei suoi componenti, ha effettuato test relativi all?attivit? scavenger sull?ossido nitrico ovvero all?azione antinfiammatoria. La determinazione in vitro dell'attivit? scavenger sull?ossido di azoto pu? essere un utile indice dell'attivit? antinfiammatoria. L'ossido nitrico (NO), infatti, ? un radicale libero a emivita breve e un messaggero intercellulare prodotto da una variet? di cellule di mammifero, come i macrofagi, neutrofili, piastrine, fibroblasti, cellule endoteliali, neuronali e muscolari lisce. NO media una variet? di eventi biologici che vanno dalla vasodilatazione, neurotrasmissione, inibizione dell?adesione e dell'aggregazione piastrinica, ma risulta essere coinvolto anche in una vasta gamma di patologie a carattere infiammatorio Finally, the Applicant in support of the properties? of the drink and of the synergistic effect of its components, has carried out tests relating to the activity? scavenger on nitric oxide or anti-inflammatory action. The in vitro determination of the activity? scavenger on? nitrogen oxide can? be a useful index of the activity? anti-inflammatory. Nitric oxide (NO), in fact, ? is a short-lived free radical and an intercellular messenger produced by a variety of of mammalian cells, such as macrophages, neutrophils, platelets, fibroblasts, endothelial, neuronal and smooth muscle cells. NO media a variety? of biological events ranging from vasodilatation, neurotransmission, inhibition of platelet adhesion and aggregation, but it also appears to be involved in a wide range of inflammatory pathologies
L'azione scavanger nei confronti dell?ossido nitrico ? stata determinata secondo il metodo di Griess, che ? comunemente utilizzato per rilevare la presenza di nitriti e misurarne la concentrazione per via spettrofotometrica. La reazione viene condotta utilizzando il reattivo di Griess, formato da una miscela di sulfanilamide e 1-naftiletilendiammina, in ambiente acido. In queste condizioni il nitrito tende a formare acido nitroso (HNO2), il quale reagendo con la sulfanilamide produce un sale di diazonio (reazione di diazotazione). Il sale di diazonio, a sua volta, d? una reazione di copulazione con l?1naftiletilendiammina originando un colorante azoico di colorazione viola che presenta un picco massimo di assorbimento alla lunghezza d'onda di 540 nm (Figura 4). The scavenger action against nitric oxide? been determined according to the method of Griess, that ? commonly used to detect the presence of nitrites and measure their concentration spectrophotometrically. The reaction is carried out using Griess's reagent, formed by a mixture of sulfanilamide and 1-naphthylethylenediamine, in an acid medium. Under these conditions, nitrite tends to form nitrous acid (HNO2), which reacts with sulfanilamide to produce a diazonium salt (diazotization reaction). The diazonium salt, in turn, d? a coupling reaction with 1-naphthylethylenediamine giving rise to a purple azo dye which has a maximum absorption peak at a wavelength of 540 nm (Figure 4).
L?esperimento ? stato condotto contemporaneamente anche su un campione di controllo, preparato in assenza di campione e contenente un?equivalente quantit? di acqua distillata. L'attivit? scavanger nei confronti dell'ossido nitrico ? stata calcolata secondo l'equazione (1). I risultati ottenuti sulla bevanda secondo l?invenzione relativi all?inibizione NO sono pari al 47,05%. The experiment? been conducted simultaneously also on a control sample, prepared in the absence of a sample and containing an?equivalent quantity? of distilled water. The activity? scavenger against nitric oxide ? was calculated according to equation (1). The results obtained on the beverage according to the invention relating to NO inhibition are equal to 47.05%.
Pertanto, la bevanda funzionale antiossidante ed antinfiammatoria secondo l?invenzione presenta composizione ottimizzata e tale da ottenere propriet? antiossidante ed antinfiammatoria massimizzate. Therefore, the antioxidant and anti-inflammatory functional drink according to the invention has an optimized composition and is such as to obtain anti-inflammatory properties. maximized antioxidant and anti-inflammatory.
Un altro vantaggio della bevanda funzionale antiossidante ed antinfiammatoria secondo l?invenzione ? di essere composta da ingredienti ed estratti di piante comuni e disponibili nell?area mediterranea oltre a una miscela ottimizzata di acido ialuronico. Another advantage of the functional antioxidant and anti-inflammatory drink according to the invention is to be composed of ingredients and extracts of plants common and available in the Mediterranean area as well as an optimized blend of hyaluronic acid.
Infine, la bevanda funzionale antiossidante ed antinfiammatoria secondo l?invenzione ha un metodo di produzione semplice ed economico. Finally, the antioxidant and anti-inflammatory functional beverage according to the invention has a simple and economical production method.
Risulta, infine, chiaro che alla bevanda funzionale antiossidante ed antinfiammatoria ed al suo metodo di produzione secondo l?invenzione qui descritti e illustrati possono essere apportate modifiche e varianti senza per questo uscire dall?ambito protettivo della presente invenzione, come definito nelle rivendicazioni allegate. Finally, it is clear that modifications and variations can be made to the antioxidant and anti-inflammatory functional drink and to its production method according to the invention described and illustrated without thereby departing from the protective scope of the present invention, as defined in the attached claims.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102021000002531A IT202100002531A1 (en) | 2021-02-04 | 2021-02-04 | FUNCTIONAL ANTIOXIDANT AND ANTI-INFLAMMATORY DRINK |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102021000002531A IT202100002531A1 (en) | 2021-02-04 | 2021-02-04 | FUNCTIONAL ANTIOXIDANT AND ANTI-INFLAMMATORY DRINK |
Publications (1)
Publication Number | Publication Date |
---|---|
IT202100002531A1 true IT202100002531A1 (en) | 2022-08-04 |
Family
ID=75252785
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT102021000002531A IT202100002531A1 (en) | 2021-02-04 | 2021-02-04 | FUNCTIONAL ANTIOXIDANT AND ANTI-INFLAMMATORY DRINK |
Country Status (1)
Country | Link |
---|---|
IT (1) | IT202100002531A1 (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006056809A (en) | 2004-08-18 | 2006-03-02 | Yoshiaki Kawasaki | Beauty drink containing hyaluronic acid and n-acetylglucosamine |
WO2012103637A1 (en) * | 2011-02-02 | 2012-08-09 | Justbio Inc. | Functional foods and beverages with synergistic properties to promote homeostasis |
EP2545925A1 (en) * | 2011-07-12 | 2013-01-16 | Holy Stone Healthcare Co.,Ltd. | Compositions comprising hyaluronic acid for treating and preventing mucosa related diseases |
WO2015017625A1 (en) * | 2013-07-31 | 2015-02-05 | Wikifoods, Inc. | Encapsulated functional food compositions |
WO2015142702A1 (en) * | 2014-03-18 | 2015-09-24 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Composition and method to alleviate joint pain using phospholipids and roe extract |
CN105018547A (en) * | 2014-04-16 | 2015-11-04 | 惠觅宙 | Bioactive hyaluronic acid fragment, production method, application, preparation and object containing preparation |
WO2019011911A1 (en) * | 2017-07-11 | 2019-01-17 | Bermes Carlo | Medicament and beverage for improving joint and bone diseases |
-
2021
- 2021-02-04 IT IT102021000002531A patent/IT202100002531A1/en unknown
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006056809A (en) | 2004-08-18 | 2006-03-02 | Yoshiaki Kawasaki | Beauty drink containing hyaluronic acid and n-acetylglucosamine |
WO2012103637A1 (en) * | 2011-02-02 | 2012-08-09 | Justbio Inc. | Functional foods and beverages with synergistic properties to promote homeostasis |
EP2545925A1 (en) * | 2011-07-12 | 2013-01-16 | Holy Stone Healthcare Co.,Ltd. | Compositions comprising hyaluronic acid for treating and preventing mucosa related diseases |
WO2015017625A1 (en) * | 2013-07-31 | 2015-02-05 | Wikifoods, Inc. | Encapsulated functional food compositions |
WO2015142702A1 (en) * | 2014-03-18 | 2015-09-24 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Composition and method to alleviate joint pain using phospholipids and roe extract |
CN105018547A (en) * | 2014-04-16 | 2015-11-04 | 惠觅宙 | Bioactive hyaluronic acid fragment, production method, application, preparation and object containing preparation |
WO2019011911A1 (en) * | 2017-07-11 | 2019-01-17 | Bermes Carlo | Medicament and beverage for improving joint and bone diseases |
Non-Patent Citations (2)
Title |
---|
ANONYMOUS: "Laboratoires Copmed", 14 December 2017 (2017-12-14), pages 1 - 116, XP055580261, Retrieved from the Internet <URL:https://pdfsecret.com/download/livret-dinformations-produits_5a32169cd64ab2123390aa0c_pdf> [retrieved on 20190411] * |
SHUKLA MEENAKSHI ET AL: "Bioavailable constituents/metabolites of pomegranate (Punica granatum L) preferentially inhibit COX2 activity ex vivo and IL-1beta-induced PGE2 production in human chondrocytes in vitro", JOURNAL OF INFLAMMATION, BIOMED CENTRAL, LONDON, GB, vol. 5, no. 1, 13 June 2008 (2008-06-13), pages 9, XP021037132, ISSN: 1476-9255 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Amaeze et al. | Evaluation of antioxidant activity of Tetracarpidium conophorum (Müll. Arg) Hutch & Dalziel leaves | |
Almeida et al. | Bioactive compounds and antioxidant activity of fresh exotic fruits from northeastern Brazil | |
Christine | Grape products and oral health | |
Denev et al. | Solid-phase extraction of berries’ anthocyanins and evaluation of their antioxidative properties | |
Vasco et al. | Total phenolic compounds and antioxidant capacities of major fruits from Ecuador | |
Rancan et al. | Protection against UVB irradiation by natural filters extracted from lichens | |
Wolfe et al. | Cellular antioxidant activity (CAA) assay for assessing antioxidants, foods, and dietary supplements | |
Banerjee et al. | In vitro study of antioxidant activity of Syzygium cumini fruit | |
Kim et al. | The antioxidant activity and the bioactive compound content of Stevia rebaudiana water extracts | |
Ozgen et al. | Chemical and antioxidant properties of pomegranate cultivars grown in the Mediterranean region of Turkey | |
Zheng et al. | Oxygen radical absorbing capacity of phenolics in blueberries, cranberries, chokeberries, and lingonberries | |
Kong et al. | Analysis and biological activities of anthocyanins | |
Katalinić et al. | Antioxidant effectiveness of selected wines in comparison with (+)-catechin | |
Piljac-Žegarac et al. | Antioxidant properties and phenolic content of different floral origin honeys | |
Zielińska et al. | Antioxidant activity of flavone C-glucosides determined by updated analytical strategies | |
Heleno et al. | Chemical composition, antioxidant activity and bioaccessibility studies in phenolic extracts of two Hericium wild edible species | |
Roy et al. | In vitro techniques to assess the proficiency of skin care cosmetic formulations | |
da Silva et al. | Functional tea from a Brazilian berry: Overview of the bioactives compounds | |
Santos et al. | Evaluation of chemical constituents and antioxidant activity of coconut water (Cocus nucifera L.) and caffeic acid in cell culture | |
Netzel et al. | Renal excretion of antioxidative constituents from red beet in humans | |
Gong et al. | Phytochemical profiles of rice and their cellular antioxidant activity against ABAP induced oxidative stress in human hepatocellular carcinoma HepG2 cells | |
Loganayaki et al. | In vitro antioxidant properties of indigenous underutilized fruits | |
Arancibia-Avila et al. | Partial characterization of a new kind of Chilean Murtilla-like berries | |
Shivembe et al. | Determination of vitamin C and total phenolic in fresh and freeze dried blueberries and the antioxidant capacity of their extracts | |
Hu et al. | Saskatoon berries (Amelanchier alnifolia Nutt.) scavenge free radicals and inhibit intracellular oxidation |